news Trevi Therapeutics Announces Pricing of $55 Million Public Offering09/23/2022Trevi Therapeutics Announces Proposed Public Offering09/22/2022Trevi Therapeutics Announces Positive Data from Full Set of Subjects in Phase 2 CANAL Trial of Haduvio™ in the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis09/19/2022 VIEW ALL NEWS contact Trevi Therapeutics 195 Church Street, 14th Floor New Haven, CT 06510 map (203) 304-2499 email us
